{"id":1114,"date":"2026-01-02T14:30:22","date_gmt":"2026-01-02T14:30:22","guid":{"rendered":"https:\/\/wickedsister.evit.com.au\/index.php\/2026\/01\/02\/myelin-targeting-drug-lucid-ms-inches-closer-to-testing-in-patients\/"},"modified":"2026-01-02T14:30:22","modified_gmt":"2026-01-02T14:30:22","slug":"myelin-targeting-drug-lucid-ms-inches-closer-to-testing-in-patients","status":"publish","type":"post","link":"https:\/\/wickedsister.evit.com.au\/index.php\/2026\/01\/02\/myelin-targeting-drug-lucid-ms-inches-closer-to-testing-in-patients\/","title":{"rendered":"Myelin-targeting drug Lucid-MS inches closer to testing in patients"},"content":{"rendered":"<p><a href=\"https:\/\/multiplesclerosisnewstoday.com\/news-posts\/2026\/01\/02\/myelin-targeting-drug-lucid-ms-inches-closer-clinical-testing\/\" title=\"Myelin-targeting drug Lucid-MS inches closer to testing in patients\" rel=\"nofollow\"><img loading=\"lazy\" decoding=\"async\" width=\"800\" height=\"400\" src=\"https:\/\/multiplesclerosisnewstoday.com\/wp-content\/uploads\/2024\/12\/ClinicalTrialsClipboard-800x400.png\" class=\"webfeedsFeaturedVisual wp-post-image\" alt=\"An oversized red pen ticks boxes marked &quot;Clinical&quot; and &quot;Trials&quot; on a checklist attached to a clipboard.\" style=\"margin: auto;margin-bottom: 15px;max-width: 100%\" data-wp-pid=\"144170\" \/><\/a><\/p>\n<p>Quantum Biopharma has completed dosing in two toxicology studies requested by the U.S. Food and Drug Administration (FDA) that aim to support the launch of clinical studies of Lucid-MS, an experimental treatment for multiple sclerosis (MS) that&#8217;s designed to slow myelin loss. The 180-day toxicity and toxicokinetic studies were designed to evaluate any potential harmful [&#8230;]<\/p>\n<p>The post <a href=\"https:\/\/multiplesclerosisnewstoday.com\/news-posts\/2026\/01\/02\/myelin-targeting-drug-lucid-ms-inches-closer-clinical-testing\/\">Myelin-targeting drug Lucid-MS inches closer to testing in patients<\/a> appeared first on <a href=\"https:\/\/multiplesclerosisnewstoday.com\">Multiple Sclerosis News Today<\/a>.<\/p>\n<p><em>Source: <a href=\"https:\/\/multiplesclerosisnewstoday.com\/news-posts\/2026\/01\/02\/myelin-targeting-drug-lucid-ms-inches-closer-clinical-testing\/\" rel=\"nofollow noopener\" target=\"_blank\">multiplesclerosisnewstoday.com<\/a><\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Quantum Biopharma has completed dosing in two toxicology studies requested by the U.S. Food and Drug Administration (FDA) that aim to support the launch of clinical studies of Lucid-MS, an experimental treatment for multiple sclerosis (MS) that&#8217;s designed to slow myelin loss. The 180-day toxicity and toxicokinetic studies were designed to evaluate any potential harmful&#8230;<\/p>\n","protected":false},"author":0,"featured_media":1115,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[11,15,9,8,13,14,12,10],"class_list":["post-1114","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-multiple-sclerosis-research","tag-brain-repair","tag-marburg-type-ms","tag-ms","tag-multiple-sclerosis","tag-myelin","tag-neuroregeneration","tag-oligodendrocyte","tag-remyelination"],"_links":{"self":[{"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/posts\/1114","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/comments?post=1114"}],"version-history":[{"count":0,"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/posts\/1114\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/media\/1115"}],"wp:attachment":[{"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/media?parent=1114"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/categories?post=1114"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/tags?post=1114"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}